DAVID FRIEDMAN
- Active Clients
- 2
- TTM Spend
- $617,500
- Total Filings
- 7
- Active Since
- 2025
trailing 4 reported quarters
income + expenses, last 12mo
7 in the last 12 months
2 years with filings
Income & Lobbyist Activity Last 10 years, by quarter
Clients from the last four reported quarters (2) · ranked by reported income and expenses
| Client | Reported $ | Filings | Share |
|---|---|---|---|
| TEVA PHARMACEUTICALS USA, INC. | $550.0K | 4 | 89.1% |
| OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WESTBRIDGE TECHNOLOGY, INC. | $67.5K | 3 | 10.9% |
Issues lobbied last four reported quarters
| Issue | Activities | Share |
|---|---|---|
INT
Intelligence
|
3 | 30.0% |
MAN
Manufacturing
|
3 | 30.0% |
PHA
Pharmacy
|
3 | 30.0% |
SCI
Science/Technology
|
1 | 10.0% |
Government entities contacted last four reported quarters
| Entity | Contacts | Share | Type |
|---|---|---|---|
| Commerce, Dept of (DOC) | 6 | 100.0% | Agency |
Revolving door lobbyists active in the last 12 months
1 of 1 lobbyist (100%) listed a prior covered government position on a lobbying filing.
- DAVID FRIEDMAN
- U.S. Amb. to Israel 2017-2021
Political contributions semiannual LD-203 reports by the firm and its lobbyists
2 reports on file for 2025 (latest version of each); 2 reported no contributions.
No itemized contributions on these reports.
Filings 7 total
| Posted | Period | Client | Type | Income | Expenses | Activities | Lobbyists |
|---|---|---|---|---|---|---|---|
| 2026-07-17 | 2026 Q2 | TEVA PHARMACEUTICALS USA, INC. | 2nd Quarter - Report (No Activity) |
$100.0K | — | 0 | 0 |
| 2026-07-17 | 2026 Q2 | OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WESTBRIDGE TECHNOLOGY, INC. | 2nd Quarter - Report |
$33.8K | — | 1 | 1 |
| 2026-04-20 | 2026 Q1 | OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WESTBRIDGE TECHNOLOGY, INC. | 1st Quarter - Report |
$33.8K | — | 1 | 1 |
| 2026-04-20 | 2026 Q1 | TEVA PHARMACEUTICALS USA, INC. | 1st Quarter - Report |
$250.0K | — | 2 | 1 |
| 2026-04-20 | 2026 Q1 | OSY TECHNOLOGIES S.A.R.L. AND ITS SUBSIDIARY WESTBRIDGE TECHNOLOGY, INC. | Registration - Amendment |
— | — | 2 | 1 |
| 2026-01-15 | 2025 Q4 | TEVA PHARMACEUTICALS USA, INC. | 4th Quarter - Report |
$200.0K | — | 2 | 1 |
| 2025-12-17 | 2025 Q4 | TEVA PHARMACEUTICALS USA, INC. | Registration |
— | — | 2 | 1 |
Lobbyists active in the last 12 months (1)
- DAVID FRIEDMAN · prior govt